Zota Health Care Ltd's Q4FY25 Quarter Results
- 30 May 2025
Result Summary
- Zota Health Care Ltd reported a 31.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 35.9%.
- Its expenses for the quarter were down by 34.6% QoQ and up 47.1% YoY.
- The net profit decreased 63.5% QoQ and increased 163.1% YoY.
- The earnings per share (EPS) of Zota Health Care Ltd declined at 2.6 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 50.09 | 72.63 | 36.87 | -31.0% | 35.9% |
Total Expenses | 59.60 | 91.11 | 40.51 | -34.6% | 47.1% |
Profit Before Tax | -9.51 | -18.48 | -3.09 | -48.5% | 207.8% |
Tax | -2.59 | 0.46 | -0.46 | -663.0% | 463.0% |
Profit After Tax | -6.92 | -18.94 | -2.63 | -63.5% | 163.1% |
Earnings Per Share | -2.60 | -6.30 | -1.10 | -58.7% | 136.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Zota Health Care Ltd is a company primarily engaged in the pharmaceuticals and healthcare industry. It specializes in the manufacturing and distribution of pharmaceutical products, including formulations and nutraceuticals. The company has a presence in both domestic and international markets, serving a wide range of healthcare needs. While recent specific developments are not provided, Zota Health Care Ltd operates in a competitive sector that is characterized by ongoing innovation and regulatory changes. The company’s product portfolio and strategic initiatives play a critical role in its market positioning and financial performance.
Revenue
During the fourth quarter of the financial year 2025 (Q4FY25), Zota Health Care Ltd reported a total income of ₹50.09 crores. This reflects a decrease of 31.0% compared to the previous quarter (Q3FY25), where the total income was ₹72.63 crores. However, when compared to the same quarter in the previous year (Q4FY24), there is a 35.9% increase in total income from ₹36.87 crores. The year-over-year growth indicates an improvement in revenue generation compared to the previous year, despite a quarter-over-quarter decline.
Profitability
In terms of profitability, Zota Health Care Ltd recorded a loss before tax of ₹9.51 crores in Q4FY25. This marks a reduction in loss by 48.5% from the loss before tax of ₹18.48 crores in Q3FY25. Year-over-year, the loss before tax widened by 207.8% from ₹3.09 crores in Q4FY24. The tax for the quarter was accounted as a negative value of ₹2.59 crores, signifying a reversal of tax provisions or benefits. Consequently, the profit after tax stood at a loss of ₹6.92 crores, which is an improvement from the previous quarter loss of ₹18.94 crores by 63.5%, but a significant increase in loss compared to the loss of ₹2.63 crores in Q4FY24 year-over-year. Earnings per share (EPS) also improved quarter-over-quarter from ₹-6.30 to ₹-2.60, though it deteriorated when compared to the previous year’s figure of ₹-1.10.
Operating Metrics
The operating expenses for Zota Health Care Ltd were reported at ₹59.60 crores in Q4FY25, which is a 34.6% reduction from Q3FY25 where the expenses were ₹91.11 crores. However, there is a 47.1% increase in expenses compared to Q4FY24, which had total expenses of ₹40.51 crores. The substantial decrease in expenses on a quarter-over-quarter basis suggests a reduction in operational outlay or cost management efforts. Despite the decrease in expenses from the previous quarter, the year-over-year increase suggests an expansion or escalation in costs associated with operations. The financial data indicates significant variations in operational metrics both on a quarterly and annual basis, reflecting the dynamics of cost management in the company’s operational framework.